Treatment for Migraine

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Brigham and Womens Hospital, Boston, MA
Migraine+1 More
Eligibility
18+
Female
Eligible conditions
Select

Study Summary

This study is evaluating whether mindfulness training specifically for pain can be offered to migraine patients.

See full description

Eligible Conditions

  • Migraine

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Migraine

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome and 12 secondary outcomes in patients with Migraine. Measurement will happen over the course of one year.

one year
Change in cortisol levels.
Change in depression and anxiety.
Change in distress tolerance.
Change in headache-related disability
Change in migraine severity, duration, and medication use.
Change in mindfulness.
Change in pain acceptance and pain expectancy.
Change in pain catastrophizing.
Change in perceived stress.
Change in physical activity.
Change in quality of life.
Feasibility of a randomized controlled trial of ACT
Preliminary data on the effectiveness of ACT on migraine frequency and migraine disability

Trial Safety

Safety Progress

1 of 3

Other trials for Migraine

Trial Design

2 Treatment Groups

ACT
1 of 2
usual care
1 of 2
Active Control

This trial requires 100 total participants across 2 different treatment groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

ACT
Behavioral
An 8-week mindfulness-based group therapy.
usual careSubjects randomized to the usual care control group will continue using their usual medical care as prescribed by their physician.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: one year
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly one year for reporting.

Who is running the study

Principal Investigator
C. A. B.
Carolyn A. Bernstein, Principal Investigator
Brigham and Women's Hospital

Closest Location

Brigham and Womens Hospital - Boston, MA

Eligibility Criteria

This trial is for female patients aged 18 and older. There are 7 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Women ages 18-65
Diagnosis of episodic migraine (according to International Classification for Headache Diagnosis criteria)
4-14 migraine days per month over the past 3 months
No change in medication in the past 3 months
Greater than 1 year of migraines
Agreeable to participate, commit to all study procedures and to be randomized to either group
Fluent in English

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Migraine by sharing your contact details with the study coordinator.